Provectus Biopharmaceuticals Inc (PVCT)

$0.08 -0.01 (-15.19%)
Market Cap 40.85M
Revenue (ttm) 620,000.00
Net Income (ttm) -4.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -767.74%
Debt to Equity Ratio 0.00
Volume 825,500
Avg Vol 215,988
Day's Range N/A - N/A
Shares Out 420.28M
Stochastic %K 60%
Beta 0.59
Analysts Strong Buy
Price Target $3.50

Latest News on PVCT

No data available.